|
A supplemental report is being submitted due to completion of the investigation on 11-aug-2025.Additional information received 3/17/2025: 1.Are images of the device or procedure available? n/a, yes, no\n no.2.At what stage of the procedure did the complaint occur? unpacking or preparation, insertion, during stent placement, \nremoving the introducer post stent placement during stent placement.3.Was a sphincterotomy performed prior to use of the stent device? n/a, yes, no yes.4.Was balloon dilation performed prior to use of the stent device? n/a, yes, no dilation perform with sbdc-7 fr.5.What was the length and diameter of the stricture? 4 cm.6.What brand of endoscope was used with the device? olympus-180.7.Was the product inspected for kinks or damage before use? n/a, yes, no yes.8.What was the position of the elevator during deployment? n/a, open, closed open.9.Was the delivery system tracked around a tight angle in the patient anatomy or around a tight angle in an endoscope? \nn/a, yes, no\n no.10.Was the device flushed through both flushing port before the procedure, as per ifu? n/a, yes, no.Yes.11.Details of the wire guide used (name, diameter, hydrophilic)?\n hydrajag-035-450.12.What was the target location for the stent?\n hepatic duct.13.Was the red safety lock removed before inserting the delivery system? n/a, yes, no\n no.14.Was the red safety lock removed before stent deployment? n/a, yes, no\n yes.15.Was the patient's anatomy tortuous?\n no.16.Did the patient exhibit altered anatomy? n/a, yes, no no.17.If yes, please specify the type of altered anatomy: _____ na.18.Did the patient have any pre-existing conditions? n/a, yes, no yes.19.If yes, please state the specific condition(s): ____ hepatic duct structure.20.Was resistance encountered when advancing the wire guide to the target location? n/a, yes, no.No.21.If yes, how did the physician deal with this resistance? na.22.Was resistance encountered when advancing the delivery system to the target location? n/a, yes, no.No.23.If yes, how did the physician deal with this resistance? na.24.Was there resistance felt passing the delivery system through the stricture? n/a, yes, no.No.25.Was any damage noted on the wire guide before, during or after the procedure? n/a, yes, no.No.26.Did the tip of the delivery system cross the target location? yes 27.Was the handle pulled toward the hub during deployment? n/a, yes, no yes 28.Was the delivery system pushed during deployment? n/a, yes, no no 29.Was the stent being placed through the side wall of a previously placed stent? n/a, yes, no n/a 30.Was the stent deployed smoothly / without resistance? n/a, yes, no no (during deployment after partialy deploy the stent its got stuck and after appling force it got break and half of the stent was remain in sheath/ broken stent removed by using forcep.31.Was the stent fully deployed before removing the delivery system from the patient? n/a, yes, no no 32.Did any part of the product snag/get caught on the stent when removing the delivery system? n/a, yes, no no 33.Was post-dilation performed after the placement of the stent? n/a, yes, no no 34.Did the patient require any additional procedures as a result of this event? n/a, yes, no no 35.If yes, what intervention was required? na 36.Was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? [n/a, same procedure, another day same procedure 37.Were any other defects (other than the complaint issue) observed on the delivery system prior to return? [n/a, yes, no] no 38.If yes, please specify what other defect(s) were observed: na query reply_(b)(6) 2024: the hospital protocol is to have the products discarded.But for this case the physician wanted our team to evaluate the device, hence the same device was returned back.There was no negative outcome on the patient and the procedure was completed with a new device.
|